• Home
  • Blog
  • Blog
  • Varicose Veins Associated with Restless Legs Syndrome

Varicose Veins Associated with Restless Legs Syndrome

Dr Karl A Ekbom proposed venous disease as a cause of restless leg syndrome (RLS) in 1944. A study by CA Hayes et al from north Texas in 2008 examined the effect of endovenous laser ablation (EVLA) treatment in patients with concurrent restless leg syndrome and duplex ultrasound proven superficial venous insufficiency (SVI).

Thirty five patients with moderate to very severe RLS and duplex proven SVI completed an International RLS rating scale (IRLS) questionnaire and underwent standard ultrasound examination to objectively measure the baseline severity of their conditions. They were separated into two groups, operative and non operative. The operative cohort underwent EVLA of refluxing superficial axial veins and ultrasound guided sclerotherapy (UGS) of the remaining associated varicose veins with foamed sodium tetradecyl sulphate. All patients then completed a follow up IRLS questionnaire and the scores were compared.

The EVLA treated group decreased the mean IRLS score by 21.4 points from 26.9 to 5.5.

A total of 89% of patients enjoyed a decrease in their score of greater than or equal to 15 points. 84% of patients indicated their symptoms had largely or completely been alleviated.

Not all people with restless leg syndrome have varicose veins, and not all people with varicose veins have restless legs, however if you have both , treatment of the venous incompetence may significantly relieve symptoms.

Consulatation at Palm Clinic with Dr Sam DunnConsulatation at Palm Clinic with Dr Sam Dunn

Why Palm Clinic?

Our highly skilled medical team treat you with care and understanding.

Have a question
or want to make an appointment?

Botox®  is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow’s feet round the eyes. Botox® has risks and benefits. Ask your doctor if Botox® is right for you. If you have side effects, see your doctor. You will need to pay for Botox® and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz. Botox® treatment lasts about 4 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals.(Contains botulinum toxin A 50,100 & 200 units). Allergan (NZ) Limited, Auckland.

Juvederm Ultra™ & Juvederm Ultra Plus™ are medical devices Class III for the filling of medium size and deep facial wrinkles by injection into the skin and for creating definition and volume in the lips. Contains 24mg/mL. cross-linked hyaluronic acid. Juvederm has risks and benefits. Cautions: Use in an area that has been treated with another dermal filler, people with autoimmune disease, or who are pregnant, breastfeeding, under 18 years of age or have an increased susceptibility to keloid formation and hypertrophic scarring. People on blood thinning medicines. Possible side effects: injection site inflammatory reactions (redness/swelling, itching/pain on pressure) induration or nodules; discolouration; weak filling effect. If you have side effects or concerns speak to your doctor. Product and treatment costs will apply. Note: Juvederm treatment lasts about 12-24 months. For product information check with your doctor or product information at Allergan (NZ) Limited, Auckland. 

Take advantage of our Interest Free Payment plans to cover the cost of your treatment.
To apply online go to: www.qmastercard.co.nz and click on APPLY NOW
Talk to our staff today to find out more about our flexible payment options.
* Lending criteria, fees, terms and conditions apply.

Q CARD sample card image
Q CARD sample mastercard image

Please note that individual results may vary from patient to patient and the information provided on our website is only a guide to possible results.